Drug profile · INN
palivizumab
SYNAGIS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
palivizumab (SYNAGIS) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
INN palivizumab
Brand SYNAGIS
Formulation VIAL
ATC code J06BD01
Frequently asked questions
What is palivizumab?
palivizumab (SYNAGIS) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for palivizumab?
SYNAGIS is a marketed brand name for palivizumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of palivizumab?
palivizumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.